Inner Logic Raises $11.5M to Build the Simulation Platform Autonomous Surgery Has Been Missing
AI-summarised brief · reviewed before publication
Baltimore startup Inner Logic, formerly Semaphor, secured $11.5 million in seed funding on July 22, 2026 to develop a simulation platform that enables autonomous surgical device makers to validate performance before clinical trials. The round was led by General Catalyst and Bison Ventures, with participation from J2VP, Defined, PTX, Valia Ventures, Page One, Alumni Ventures, and Flare. The funding follows FDA guidance on computational modeling and simulation, opening a regulatory pathway for simulation‑based evidence. Inner Logic’s platform generates thousands of virtual patients from real procedural data, allowing rapid testing of autonomous systems across diverse anatomical scenarios.
💡 Why It Matters
- · By providing a scalable, evidence‑based testing framework, Inner Logic removes a critical bottleneck that has stalled autonomous surgery, potentially accelerating safe deployment of AI‑driven surgical robots.
